Global Blood Transfusion Diagnostics Market Report – By Product Type (Instruments, Reagents & Kits, and Other Product Types), By Application (Blood Screening and Blood Group Typing), By End User (Hospital Based Laboratories, Independent Laboratories, and Blood Banks), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

The global blood transfusion diagnostics market Market size is expected to be worth around USD 9,095 Mn by 2032 from USD 4,702 Mn in 2022, growing at a CAGR of 7% during the forecast period from 2022 to 2032.

Blood transfusion diagnostics refers to the tests performed on blood and blood components before transfusing them to patients. Each blood unit must be tested for disease screening and blood group typing to prevent the transmission of infection or adverse reactions.

Market Scope

Type Analysis

The types of blood transfusion diagnostics include instruments, reagents & kits, and others. These kits are used to collect and transfuse blood. The technologies involved in blood transfusion diagnostics are nucleic acid amplification, western blot, the rapid test used for different applications such as disease screening and blood grouping, ELISA, and fluorescence assay.

The majority of the growth in the market can be attributed to the easy availability of the products needed to screen both donor and recipient samples and the frequent purchase of these products. Another driving factor of this segment’s expansion is the availability of a wide range of donor screening, blood grouping, typing reagents, kits, and assays made by international and domestic players.

In addition, the market expansion is anticipated to be fueled in the upcoming years by the increasing availability of rapid diagnostic kits for safe blood transfusion.

Due to the consistent sales of instruments and, reagents & kits for blood group typing and screening of donor and recipient samples, the reagents & kits segment held most of the market share in 2022. Despite this, the instruments segment had a relatively minor share in 2022 due to their longer shelf life and higher cost.

Application Analysis

Blood screening, as well as blood group typing, are the application-based segments of this market. Due to rising global rates of Transmissible Transfusion Infections (TTI), the blood screening segment dominate the global market in 2022.

Due to the introduction of automated analyzers and rising demand for group typing and cross-matching tests prior to transfusion therapy to determine the compatibility of donor and recipient blood samples, the blood group typing market is anticipated to expand at a significant CAGR.

End-User Analysis

The market is segmented into hospital-based laboratories and, independent labs & blood banks by end users. Due to the rising number of blood transfusion procedures performed in hospitals, it is anticipated that the hospital-based laboratories segment will experience significant growth over the course of the forecast period.

Additionally, the market is expected to expand as more hospitals actively implement blood management programs to save blood units and make the transfusion process easier. In the year 2022, the market was dominated by the independent laboratories and blood banks segment.

The large number of blood transfusions performed in these settings and the growing number of independent blood banks and laboratories in both developed and developing nations are responsible for the dominance.

Key Market Segments

Based on Product Type

• Instruments
• Reagents & Kits
• Other Product Types

Based on Application

• Blood Screening
• Blood Group Typing

By End User

• Hospital Based Laboratories
• Independent Laboratories
• Blood Banks

Market Dynamics

Drivers

Increasing frequency of blood disorders

Due to the increasing frequency of blood-related disorders, like thrombocytopenia, hemophilia, cancer, etc., and Chronic Kidney Disease, the demand for complete blood transfusion and blood products has been propelled. Likely, in 2020, as per the data published on World Kidney Day, around 850 people globally were suffering from kidney disorders.

Moreover, it was noticed that one in ten adults was suffering from Chronic Kidney Disease, and this condition may become 5^th most common cause of death by the end of the year 2040.

The rise in the number of patients suffering from anemia

Anemia requires red blood cell transfusion for its treatment. Due to the increase in the number of patients suffering from anemia, the requirement for red blood cell transfusion was also increasing; this will anticipate surging the demand for blood transfusion diagnosis. World Health Organization (WHO) estimated that around 1.62 billion people worldwide were affected by anemia.

Programs in developed and growing countries are run to increase awareness about blood safety from infectious diseases. As a result, it increased the demand for diagnostics tools and blood screening tests. Therefore, the factors mentioned earlier are improving the need for global blood transfusion diagnostics.

Restraints

Bloodborne Infections

Sometimes due to blood transfusion, bloodborne infections may get transferred from donor to recipient, which can hamper the growth of the global blood transfusion diagnostics market.

Furthermore, some of the adverse side effects because of the blood transfusion system are allergic reactions, bloodborne diseases, and virus and infection illnesses that cause fever may restrain this market’s growth.

In addition, the global blood transfusion diagnostics market is being constrained due to high prices of equipment and a lack of infrastructure.

Opportunity

Factors that influence the growth of the market

Due to the need for blood transfusion because of the rise in organ transplant surgeries and the rapid increase in chronic disease, the growth of the global blood market is attributed. To overcome blood loss, patients undergoing surgical procedures need a blood transfusion.

Before transferring the blood to the patient, blood transfusion diagnostics are used to screen the blood. If this technique is not used, there will be chances of transmission of infectious diseases.

According to an article published National Institute of Health, US National Library of Medicine, around 310 million surgeries are being performed in one year. Hence, the increase in the number of procedures will result in a boost for blood transfusion diagnostics.

Trends

The rapid increase in chronic diseases

Chronic Diseases, such as cardiovascular disorders, renal disorders, and cancer, are major causes of human death around the globe. Surgical procedures usually treat these conditions.

However, surgical procedures may cause excessive blood loss. Therefore, fresh blood is given to patients to keep the patient’s blood levels.

The diagnostics are used during the reinfusion processes or blood infusion. Hence, the global blood glucose transfusion diagnostic market is growing due to the rise in chronic diseases.

According to the data published by the Indian Council of Medical Research (ICMR) and the National Institute of Cancer Prevention (NICPR), the yearly frequency of cancer in India is estimated at around 2.26 million, leading to surgical procedures in ample amounts.

COVID-19 Impact Analysis

COVID-19 hindered the growth of the market in a short period of time

The global blood transfusion diagnostic market was facing difficulties due to the sudden outbreak of Covid-19, which caused strict lockdown measures in various countries.

Covid-19 had three consequential effects on the global economy: a financial impact on businesses and financial markets, directly impacting demand and production, and causing market disruption, thereby affecting the global blood transfusion market.

Worldwide, the Covid-19 pandemic has caused significant obstacles to the healthcare system. The factor that severely impacted the growth of the blood transfusion diagnostics market is that the patients must postpone their visits because of a sudden increase in covid-19 instances across the regions. Furthermore, the shutdown resulted in supply chain problems which hampered the market’s growth rate.

Moreover, the Covid-19 pandemic has caused chaos in the health industry. Subsequently, the market faced many challenges in the supply and demand of blood banks and transfusion services, negatively affecting the Blood transfusion devices market and Blood Transfusion Devices Market.

Regional Analysis

North America accounted for the largest revenue in the market.

The market was constrained by North America, which holds the highest revenue share of 40.1% in 2022. However, it is anticipated that the segment will hold its position throughout the forecast period.

The regional market is driven by a growing awareness of health care, a high disposable income, and favorable reimbursement policies. According to data from the Community Blood Center, approximately 43,000 points of donated blood are used daily in Canada and the United States.

The United States had the largest share in NA. Over 600 independent donation facilities, easy access to various testing assays, and the presence of main market players are the primary contributors to its dominance.

Independent blood centers are dependable for 25% of the supply of blood collected in Canada and contain approximately 60% of blood donation in the United States.

During the forecast period, it is anticipated that the market in Asia Pacific will expand faster. Australia is becoming increasingly aware of the possibility of launching various campaigns, and India is encouraging regional expansion.

However, despite that, fewer blood transfusion diagnostic tools have been implemented in APAC due to the declining count of donors in South Korea and Singapore.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

The market is getting a lot of attention from various regulatory authorities and businesses. In order to increase the production and development of diagnostic blood tests, businesses in the global market for blood transfusion diagnostics are continuously engaging in a variety of strategic initiatives.

Key Industry Developments

• In April 2021, advanced technology in the market was introduced by EryPharm. It can produce a large volume of red blood cells and develop new blood transfusion sourcing.
• In March 2021, Bio-Rad Laboratories and F. Hoffman-La Roche entered a global partnership. The motive is to provide the customer access to Bio-Rad’s complete InteliQ and Unity QC data management solutions.

Below are some of the most prominent global blood glucose monitoring devices market players.

Market Key Players

• Hoffmann-La Roche Ltd
• Ortho Clinical Diagnostics
• Immucor, Inc.
• Bio-Rad Laboratories, Inc.
• DiaSorin S.P.A.
• Abbott
• BAG Healthcare GmbH
• Danaher
• Quotient Limited
• Grifols S.A.
• Other Key Players